Jyothy Labs Limited (JYOTHYLAB) AI Stock Analysis

• Market Cap: ₹80.60B
• Dividend Yield: 1.24%
• Average Volume (3M): 26.54K
• Price to Earnings (P/E): 32.0
• Beta (1Y): 0.92
• Revenue Growth: 1.62%
• EPS Growth: -7.32%
• Country: IN
• Employees: 2,943
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 2.20
• Shares Outstanding: 367,214,500
• 10 Day Avg. Volume: 19,687
• 30 Day Avg. Volume: 26,541
• PEG Ratio: 109.35
• Price to Book (P/B): 5.89
• Price to Sales (P/S): 4.21
• P/FCF Ratio: 47.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹270.00
• Price Target Upside: -2.32% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): 9.85
• Revenue Forecast (FY): ₹29.41B

• Rating: 61 Neutral
• Price Target: ₹232.00 ▼(-16.06% Downside)
• Action: Reiterated Date: 11/26/25
• Date: Action: Reiterated 11/26/25

Jyothy Labs Limited's overall stock score is primarily driven by its strong financial performance, characterized by consistent revenue and profit growth, effective cost management, and solid cash flow generation. However, the technical analysis indicates bearish momentum, with the stock trading below key moving averages and showing oversold conditions. The valuation suggests the stock may be overvalued, with a high P/E ratio and modest dividend yield. These factors collectively result in a moderate overall stock score.

Positive Factors

Revenue Growth

Sustained revenue growth over multiple years demonstrates increasing market penetration and repeat purchase behavior in staple categories. For a volume-driven FMCG player, this underpins durable topline expansion, better operating leverage, and capacity to fund brand investment and distribution over the next 2–6 months.

Balance Sheet Health

Very low and declining leverage provides financial flexibility to navigate input cost swings, invest in working capital or M&A, and sustain marketing spend without refinancing risk. A strong balance sheet reduces short-term liquidity stress and supports steady long-term execution in consumer staples.

Cash Generation

Consistent free cash flow growth and solid conversion of income to cash allow funding of capex, marketing, and modest shareholder returns without heavy borrowing. Strong cash generation is a durable advantage for FMCG, supporting brand upkeep and distribution rollouts over several quarters.

Negative Factors

Earnings Per Share Growth

Negative EPS growth indicates earnings per share contraction despite revenue gains, pointing to margin pressure, cost inflation, or dilution. Persisting EPS decline can undermine return metrics and limit retained earnings available for reinvestment or dividends over the medium term.

Capital Structure Efficiency

A very high equity ratio limits the company’s use of efficient leverage and tax shields, potentially lowering return on equity versus peers using modest debt. Over time this can constrain accelerated growth initiatives or raise the cost of capital for expansion in competitive FMCG segments.

Margin and Cash Flow Volatility

Volatility in EBIT margins combined with a recent decline in operating cash flow suggests earnings and cash generation are exposed to cost or working-capital swings. If sustained, this can force higher promotional intensity or price hikes, eroding durable profitability and funding flexibility.

Jyothy Labs Limited Business Overview & Revenue Model

Company Description

Jyothy Labs Limited, together with its subsidiaries, engages in manufacturing and marketing fabric care, dishwashing, personal care, and household insecticides products in India and internationally. The company operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, Laundry Services, and Others segments. The Dishwashing segment offers dish wash scrubbers and scrubber steel, as well as dish wash bars, liquids, and powders under the Pril and Exo brands. The Fabric Care segment provides fabric whiteners, fabric enhancers, bar soaps, and detergent powders under the Henko, Mr. White, Ujala, and More light brands. The Household Insecticides segment offers mosquito repellent coils, liquids, and cards, as well as insect repellents and air care products under the Maya, T- Shine, and Maxo brands. The Personal Care segment provides body soaps, face washes, toothpastes, deodorants, talcum powders, after shave products, hand sanitizers, and moisturizers under the Margo, Fa, and Neem Active brands. The Laundry Services segment provides dry cleaning and laundry services. The Others segment offers incense sticks, toilet and vegetable cleaner and floor shine products under the Joy of shine brand. The company was formerly known as Jyothy Laboratories Limited and changed its name to Jyothy Labs Limited in July 2019. Jyothy Labs Limited was founded in 1983 and is based in Mumbai, India.

How the Company Makes Money

Jyothy Labs makes money by selling branded FMCG products to the trade (distributors, wholesalers, modern retail chains, and other retail channels) across India, generating revenue primarily from the sale of packaged home and personal care items. Its revenue model is volume-driven: the company manufactures (or sources/manufactures through third parties where applicable) products, invests in brand-building and marketing, and sells across a wide distribution footprint; earnings scale with consumer demand, market penetration, and repeat purchase frequency typical of staples and cleaning categories. Key revenue streams are the company’s core product segments—home care and fabric care (e.g., detergents/fabric care products) and household cleaning (e.g., dishwash and surface/household cleaners)—with additional contribution from personal care offerings where present. Profitability is influenced by product mix, pricing, promotional intensity, distribution reach, and input costs (notably commodity-linked raw materials and packaging). Specific details on segment-level revenue splits, major customer concentration, or material partnerships are null.

Jyothy Labs Limited Financial Statement Overview

Summary

Jyothy Labs Limited exhibits strong financial performance with consistent revenue and profit growth, effective cost management, and solid cash flow generation. The balance sheet is robust with low leverage, although a high equity ratio could limit financial flexibility. The company should focus on maintaining cash flow efficiency to sustain growth momentum.

Income Statement

Jyothy Labs Limited shows strong revenue growth with a consistent increase from INR 17,097 million in 2020 to INR 28,469 million in 2025. The gross profit margin has improved significantly, indicating efficient cost management and pricing strategies. Net profit margin has also remained stable, contributing to overall profitability. The EBIT and EBITDA margins reflect robust operational efficiency. However, attention is needed on the slight volatility in EBIT margins over the years.

Balance Sheet

The company maintains a solid balance sheet with a favorable debt-to-equity ratio, decreasing from 0.27 in 2020 to 0.03 in 2025, showcasing effective debt management and strong equity base. The return on equity is commendable, enhancing investor confidence. However, the equity ratio suggests a high reliance on equity financing, which could limit leverage benefits.

Cash Flow

Jyothy Labs has demonstrated strong cash flow generation with positive free cash flow growth. The operating cash flow to net income ratio indicates efficient conversion of income into cash, although there was a decline in operating cash flow in recent years. The company's free cash flow to net income ratio is solid, reflecting effective capital expenditure management. However, the decline in operating cash flow from 2024 to 2025 suggests potential challenges in cash generation operations.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	28.80B	28.68B	27.61B	24.86B	21.97B	19.10B
Gross Profit	14.04B	14.39B	13.48B	10.42B	9.06B	8.92B
EBITDA	4.97B	5.05B	4.74B	3.08B	2.39B	3.09B
Net Income	3.48B	3.70B	3.69B	2.40B	1.62B	1.99B
Balance Sheet
Total Assets	21.22B	26.91B	24.01B	20.62B	20.23B	19.56B
Cash, Cash Equivalents and Short-Term Investments	8.05B	5.99B	6.16B	2.81B	2.09B	1.94B
Total Debt	537.40M	612.80M	505.60M	465.30M	1.71B	1.67B
Total Liabilities	6.84B	6.41B	5.91B	5.11B	6.20B	5.65B
Stockholders Equity	14.38B	20.50B	18.08B	15.49B	14.44B	14.29B
Cash Flow
Free Cash Flow	1.61B	2.53B	4.21B	2.93B	1.77B	3.76B
Operating Cash Flow	1.96B	3.11B	4.58B	3.29B	2.03B	4.02B
Investing Cash Flow	-1.17B	-1.61B	-3.44B	-482.90M	-317.13M	-1.29B
Financing Cash Flow	-1.44B	-1.57B	-1.35B	-2.51B	-1.67B	-2.16B

Jyothy Labs Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 276.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JYOTHYLAB, the sentiment is Negative. The current price of 276.4 is above the 20-day moving average (MA) of 244.35, above the 50-day MA of 251.64, and below the 200-day MA of 303.72, indicating a bearish trend. The MACD of -5.72 indicates Positive momentum. The RSI at 26.05 is Positive, neither overbought nor oversold. The STOCH value of 2.62 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JYOTHYLAB.

Jyothy Labs Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ZYDUSWELL	66 Neutral	₹128.49B	-90.62	―	0.28%	14.55%	-20.61%
CCL	63 Neutral	₹136.80B	31.27	―	0.52%	30.11%	23.22%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
JYOTHYLAB	61 Neutral	₹80.60B	31.99	―	1.24%	1.62%	-7.32%
BECTORFOOD	61 Neutral	₹55.50B	46.45	―	0.45%	10.82%	-8.21%
GALAXYSURF	60 Neutral	₹63.50B	30.80	―	1.07%	22.63%	-8.57%
HONASA	54 Neutral	₹87.54B	46.47	―	―	10.59%	67.55%

Jyothy Labs Limited Corporate Events

Jyothy Labs Plans Routine One-on-One Meeting With Mirabilis Investment Trust

Jyothy Labs Limited has scheduled an investor and analyst meeting with Mirabilis Investment Trust on March 12, 2026, to be held as a one-on-one interaction. The company has clarified that no unpublished price-sensitive information will be shared during this engagement and has directed stakeholders to its latest investor presentation available on its website, indicating a routine investor relations outreach rather than a strategic or operational shift.

Jyothy Labs Schedules Investor Meeting With Eternity Capital

Jyothy Labs Limited has notified stock exchanges about a scheduled investor and analyst meeting with Eternity Capital on March 11, 2026. The company clarified that the interaction will not involve sharing any unpublished price-sensitive information and directed stakeholders to its latest investor presentation available on its website, underscoring its adherence to disclosure norms and ongoing investor engagement.

The announcement signals continued effort by Jyothy Labs to maintain transparent communication with the investment community while complying with regulatory requirements. For shareholders and market participants, the meeting represents part of the company’s regular outreach rather than a disclosure of new financial or strategic information.

Jyothy Labs Shares Q3 and Nine-Month FY25 Performance in Investor Presentation

Jyothy Labs Limited has submitted to the BSE and the National Stock Exchange a copy of its investor presentation detailing the company’s performance for the quarter and nine months ended December 31, 2025. The presentation, which is also available on the company’s website, is intended to update and inform investors about its recent financial and operational results, reinforcing disclosure standards and transparency for market participants.

By formally disseminating this performance update to both major Indian exchanges, Jyothy Labs underscores its compliance with listing requirements and its engagement with the investor community. The move ensures that shareholders and potential investors have timely access to key performance information, supporting informed decision-making and aligning with best practices in corporate governance and investor relations.